Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing

Genetics in Medicine

Volumn 16, Issue 5, 2014, Pages 395-399

  Shahmirzadi, Layla ^a   Chao, Elizabeth C ^a,b   Palmaer, Erika ^a   Parra, Melissa C ^a   Tang, Sha ^a   Gonzalez, Kelly D Farwell ^a  

^a AMBRY GENETICS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

clinical exome sequencing; genetic testing in minors; incidental findings; return of results; secondary findings

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHILD; CLINICAL LABORATORY; DECISION MAKING; DIAGNOSTIC PROCEDURE; DISEASE PREDISPOSITION; EXOME; FAMILY; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HUMAN; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; MEDICOLEGAL ASPECT; MINOR (PERSON); RECESSIVE INHERITANCE; ADOLESCENT; DNA SEQUENCE; GENETICS; INFANT; INTERPERSONAL COMMUNICATION; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT PREFERENCE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DISCLOSURE; EXOME; HUMANS; INCIDENTAL FINDINGS; INFANT; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT PREFERENCE; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84899979578     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2013.153     Document Type: Article

References (39)

1. ACMG Board of Directors. Points to consider in the clinical application of genomic sequencing. Gen Med 2012;14:759-761.
2. Bell CJ, Dinwiddie DL, Miller NA, et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011;3:65-64.
3. Johnston JJ, Rubinstein WS, Facio FM, et al. Secondary variants in individuals undergoing exome sequencing: Screening of 572 individuals identifies highpenetrance mutations in cancer-susceptibility genes. Am J Hum Genet 2012;91:97-108.
4. Wolf SM, Lawrenz FP, Nelson CA, et al. Managing incidental findings in human subjects research: Analysis and recommendations. J Law Med Ethics 2008;36:219-248, 211.
5. Wolf SM, Crock BN, Van Ness B, et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012;14:361-384.
6. Wolf SM. The past, present, and future of the debate over return of research results and incidental findings. Genet Med 2012;14:355-357.
7. Van Ness B. Genomic research and incidental findings. J Law Med Ethics 2008;36:292-297, 212.
8. National Heart, Lung, and Blood Institute working group, Fabsitz RR, McGuire A, Sharp RR et al. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, LUng, and Blood Institute working group. Circ Cardiovasc Genet 2010;3:574-580.
9. Chahrour MH, Yu TW, Lim ET, et al.; ARRA Autism Sequencing Collaboration. Whole-exome sequencing and homozygosity analysis implicate depolarizationregulated neuronal genes in autism. PLoS Genet 2012;8:e1002635.
10. Berg JS, Adams M, Nassar N, et al. An informatics approach to analyzing the incidentalome. Genet Med 2013;15:36-44.
11. Lohn Z, Adam S, Birch P, Townsend A, Friedman J. Genetics professionals' perspectives on reporting incidental findings from clinical genome-wide sequencing. Am J Hum Genet 2012;999(Pt A):991-998.
12. Bredenoord AL, Kroes HY, Cuppen E, Parker M, Van Delden JJ. Disclosure of individual genetic data to research participants: The debate reconsidered. Trends Genet 2011;27:41-47.
13. Pulley J, Clayton E, Bernard GR, Roden DM, Masys DR. Principles of human subjects protections applied in an opt-out, de-identified biobank. Clin Transl Sci 2010;3:42-48.
14. McGuire AL, Lupski JR. Personal genome research: What should the participant be told? Trends Genet 2010;26:199-201.
15. Clayton EW, Haga S, Kuszler P, Bane E, Shutske K, Burke W. Managing incidental genomic findings: Legal obligations of clinicians. Genet Med 2013;15:624-629.
16. Bledsoe MJ, Clayton EW, McGuire AL, Grizzle WE, O'Rourke PP, Zeps N. Return of research results from genomic biobanks: A call for data. Genet Med 2013;15:159-160.
17. Bledsoe MJ, Clayton EW, McGuire AL, Grizzle WE, O'Rourke PP, Zeps N. Return of research results from genomic biobanks: Cost matters. Genet Med 2013;15:103-105.
18. Bledsoe MJ, Grizzle WE, Clark BJ, Zeps N. Practical implementation issues and challenges for biobanks in the return of individual research results. Genet Med 2012;14:478-483.
19. Fullerton SM, Wolf WA, Brothers KB, et al. Return of individual research results from genome-wide association studies: Experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med 2012;14:424-431.
20. Gliwa C, Berkman BE. Do researchers have an obligation to actively look for genetic incidental findings? Am J Bioeth 2013;13:32-42.
21. Clayton EW. Incidental findings in genetics research using archived DNA. J Law Med Ethics 2008;36:286-291, 212.
22. Lemke A, Bick D, Dimmock D, Simpson P, Veith R. Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: A survey study. Clin Genet 2013;84:230-236.
23. Couzin-Frankel J. Human genome 10th anniversary. What would you do? Science 2011;331:662-665.
24. Abdul-Karim R, Berkman BE, Wendler D, et al. Disclosure of incidental findings from next-generation sequencing in pediatric genomic research. Pediatrics 2013;131:564-571.
25. Biesecker LG. The Nirvana fallacy and the return of results. Am J Bioeth 2013;13:43-44.
26. Biesecker LG. Secondary variants and human subjects research. Genet Med 2013;15:157.
27. Knoppers BM, Deschênes M, Zawati MH, Tassé AM. Population studies: Return of research results and incidental findings Policy Statement. Eur J Hum Genet 2013;21:245-247.
28. Parker LS. The future of incidental findings: Should they be viewed as benefits? J Law Med Ethics 2008;36:341-351, 213.
29. Green RC, Berg JS, Grody WW, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med 2013;15:565-574.
30. Murphy J, Scott J, Kaufman D, Geller G, LeRoy L, Hudson K. Public expectations for return of results from large-cohort genetic research. Am J Bioeth 2008;8:36-43.
31. Kirschen MP, Jaworska A, Illes J. Subjects' expectations in neuroimaging research. J Magn Reson Imaging 2006;23:205-209.
32. Wilfond BS, Carpenter KJ. Incidental findings in pediatric research. J Law Med Ethics 2008;36:332-340, 213.
33. Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. ASHG, ACMG board of directors. Am J Hum Genet 1995;57:1233-1241.
34. AMA code of medical ethics' opinion on genetic testing. The virtual mentor. 2009;11:683-685.
35. Borry P, Evers-Kiebooms G, Cornel MC, Clarke A, Dierickx K. Genetic testing in asymptomatic minors: Background considerations towards ESHG recommendations. Eur J Hum Genet 2009;17:711-719.
36. Duncan RE, Savulescu J, Gillam L, Williamson R, Delatycki MB. An international survey of predictive genetic testing in children for adult onset conditions. Genet Med 2005;7:390-396.
37. Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB. 'You're one of us now': Young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet C Semin Med Genet 2008;148C:47-55.
38. Mand C, Gillam L, Delatycki MB, Duncan RE. Predictive genetic testing in minors for late-onset conditions: A chronological and analytical review of the ethical arguments. J Med Ethics 2012;38:519-524.
39. Ross LF, Ross LF, Saal HM, David KL, Anderson RR; American Academy of Pediatrics; American College of Medical Genetics and Genomics. Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med 2013;15:234-245.